<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>中睿医药评论 | wechat-feeds</title><link>http://MjM5NDA5MTQ5MQ.favicon.privacyhide.com/favicon.ico</link><description>中睿咨询致力于帮助中国本土大中型企业和具备核心资源的中小成长型企业构建企业战略和战术落地高度融合的一体化的体系。推动企业在明确战略方向指引下，实现持续成长！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 15 Jun 2021 19:15:49 +0800</pubDate><image><url>http://MjM5NDA5MTQ5MQ.favicon.privacyhide.com/favicon.ico</url><title>中睿医药评论 | wechat-feeds</title><link>http://MjM5NDA5MTQ5MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>多款新药获FDA临床许可，来自亚盛医药、亚虹医药/百济神州、三生国健</title><link>https://mp.weixin.qq.com/s/XCbD-6AUKAOhM49yksoYhw</link><description></description><content:encoded><![CDATA[多款新药获FDA临床许可，来自亚盛医药、亚虹医药/百济神州、三生国健]]></content:encoded><pubDate>Tue, 15 Jun 2021 19:07:55 +0800</pubDate></item><item><title>阿立哌唑口服溶液拟纳入优先审评</title><link>https://mp.weixin.qq.com/s/JX-CrPISFj8aeugc6Jvx9A</link><description></description><content:encoded><![CDATA[阿立哌唑口服溶液拟纳入优先审评]]></content:encoded><pubDate>Tue, 15 Jun 2021 19:07:55 +0800</pubDate></item><item><title>恒瑞PD-1新适应症获批：一线治疗鼻咽癌</title><link>https://mp.weixin.qq.com/s/TPAUBigp-imJ9LtJFzK70Q</link><description></description><content:encoded><![CDATA[恒瑞PD-1新适应症获批：一线治疗鼻咽癌]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:07:19 +0800</pubDate></item><item><title>注射剂型，石药集团抗肿瘤纳米新药获批临床</title><link>https://mp.weixin.qq.com/s/kI0NUvcqq9KXv0KoWRx1Xw</link><description></description><content:encoded><![CDATA[注射剂型，石药集团抗肿瘤纳米新药获批临床]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:07:19 +0800</pubDate></item><item><title>国产首款ADC获批上市！荣昌生物抢夺129亿市场！</title><link>https://mp.weixin.qq.com/s/KrZLikihe4qnZj8lGaunsA</link><description></description><content:encoded><![CDATA[国产首款ADC获批上市！荣昌生物抢夺129亿市场！]]></content:encoded><pubDate>Wed, 09 Jun 2021 16:48:44 +0800</pubDate></item><item><title>泽璟制药多纳非尼获批上市！首个国产肝癌一线靶向药</title><link>https://mp.weixin.qq.com/s/BLIHv4zmE9gZw5RnjgZvLQ</link><description></description><content:encoded><![CDATA[泽璟制药多纳非尼获批上市！首个国产肝癌一线靶向药]]></content:encoded><pubDate>Wed, 09 Jun 2021 16:48:44 +0800</pubDate></item><item><title>信达PD-1第3项适应症获批，一线治疗鳞状NSCLC</title><link>https://mp.weixin.qq.com/s/QzdrIXT8dyjfKhesQVg_1g</link><description></description><content:encoded><![CDATA[信达PD-1第3项适应症获批，一线治疗鳞状NSCLC]]></content:encoded><pubDate>Thu, 03 Jun 2021 17:48:01 +0800</pubDate></item><item><title>国内首家！先声药业「甲苯磺酸艾多沙班片」申报上市</title><link>https://mp.weixin.qq.com/s/MuyRvesgX49Xs_HjRNYsxQ</link><description></description><content:encoded><![CDATA[国内首家！先声药业「甲苯磺酸艾多沙班片」申报上市]]></content:encoded><pubDate>Thu, 03 Jun 2021 17:48:01 +0800</pubDate></item><item><title>2021年中国儿童用药发展趋势，行业政策汇总及解读(全)</title><link>https://mp.weixin.qq.com/s/uEIU_mden3XZCFUwPTylsg</link><description></description><content:encoded><![CDATA[2021年中国儿童用药发展趋势，行业政策汇总及解读(全)]]></content:encoded><pubDate>Tue, 01 Jun 2021 18:09:26 +0800</pubDate></item><item><title>首家过评！恒瑞医药抗菌药通过一致性评价</title><link>https://mp.weixin.qq.com/s/rbqHM7hKP39B-3KgwhGvHw</link><description></description><content:encoded><![CDATA[首家过评！恒瑞医药抗菌药通过一致性评价]]></content:encoded><pubDate>Tue, 01 Jun 2021 18:09:26 +0800</pubDate></item><item><title>首个国产一线肝细胞癌靶向药物即将获批上市</title><link>https://mp.weixin.qq.com/s/mjUrxE0-QjG5Nvx0oU_BMw</link><description></description><content:encoded><![CDATA[首个国产一线肝细胞癌靶向药物即将获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 16:39:38 +0800</pubDate></item><item><title>扬子江1类新药「注射用磷酸左奥硝唑酯二钠」获批上市</title><link>https://mp.weixin.qq.com/s/3ULeyBDt4okXBv95Kse7QQ</link><description></description><content:encoded><![CDATA[扬子江1类新药「注射用磷酸左奥硝唑酯二钠」获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 16:39:38 +0800</pubDate></item><item><title>恒瑞医药新布局，瞄准200亿市场的新药研发蓝海！</title><link>https://mp.weixin.qq.com/s/mAb3NOax6OUqX128ZAvbjw</link><description></description><content:encoded><![CDATA[恒瑞医药新布局，瞄准200亿市场的新药研发蓝海！]]></content:encoded><pubDate>Wed, 26 May 2021 19:50:36 +0800</pubDate></item><item><title>人福药业1类麻醉新药在中国获批</title><link>https://mp.weixin.qq.com/s/CoJtwWjBhsETyroP1lfy0Q</link><description></description><content:encoded><![CDATA[人福药业1类麻醉新药在中国获批]]></content:encoded><pubDate>Wed, 26 May 2021 19:50:36 +0800</pubDate></item><item><title>历时近 7 年，甘李药业精蛋白重组人胰岛素（预混 30R）正式获批</title><link>https://mp.weixin.qq.com/s/-mLGRRQHJPffxohFCo-rZg</link><description></description><content:encoded><![CDATA[历时近 7 年，甘李药业精蛋白重组人胰岛素（预混 30R）正式获批]]></content:encoded><pubDate>Mon, 24 May 2021 17:51:08 +0800</pubDate></item><item><title>百济神州first-in-class HPK1抑制剂在国内申报临床</title><link>https://mp.weixin.qq.com/s/cy1l5Td0x0Kq_L4V_9jKng</link><description></description><content:encoded><![CDATA[百济神州first-in-class HPK1抑制剂在国内申报临床]]></content:encoded><pubDate>Mon, 24 May 2021 17:51:08 +0800</pubDate></item><item><title>首个国产三代EGFR-TKI创新药！豪森阿美乐肺癌一线治疗获重大突破</title><link>https://mp.weixin.qq.com/s/Trl2EAUCxRbK7wWVs3oW5A</link><description></description><content:encoded><![CDATA[首个国产三代EGFR-TKI创新药！豪森阿美乐肺癌一线治疗获重大突破]]></content:encoded><pubDate>Thu, 20 May 2021 19:57:45 +0800</pubDate></item><item><title>刚刚！「广谱」抗癌靶向药 Larotrectinib 国内报上市</title><link>https://mp.weixin.qq.com/s/2jNC78a5O5u_fXlpwsr3rw</link><description></description><content:encoded><![CDATA[刚刚！「广谱」抗癌靶向药 Larotrectinib 国内报上市]]></content:encoded><pubDate>Thu, 20 May 2021 19:57:45 +0800</pubDate></item><item><title>CDE最新发布：第四十三批化学仿制药参比制剂 44个审议未通过（附目录）</title><link>https://mp.weixin.qq.com/s/AY753fGCtU8R0rfYkswshQ</link><description></description><content:encoded><![CDATA[CDE最新发布：第四十三批化学仿制药参比制剂 44个审议未通过（附目录）]]></content:encoded><pubDate>Mon, 17 May 2021 18:08:07 +0800</pubDate></item><item><title>2020年报大盘点：疫苗药企成绩如何？</title><link>https://mp.weixin.qq.com/s/k1u0Y0P2xNcs-J8Xe2ZSpA</link><description></description><content:encoded><![CDATA[2020年报大盘点：疫苗药企成绩如何？]]></content:encoded><pubDate>Mon, 17 May 2021 18:08:07 +0800</pubDate></item></channel></rss>